Monocytes, peripheral blood mononuclear cells, and THP-1 cells exhibit different cytokine expression patterns following stimulation with lipopolysaccharide

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Schildberger, Anita ^a   Rossmanith, Eva ^a   Eichhorn, Tanja ^a   Strassl, Katharina ^a   Weber, Viktoria ^a  

^a DANUBE UNIVERSITY KREMS   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CYTOKINE RELEASE; HUMAN; HUMAN CELL; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; THP 1; UMBILICAL VEIN ENDOTHELIAL CELL; CELL LINE; DRUG EFFECTS; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; MONONUCLEAR CELL; DRUG EFFECT;

PSEUDOMONAS AERUGINOSA;

CELL LINE; CYTOKINES; FLOW CYTOMETRY; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-8; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MONOCYTES; PSEUDOMONAS AERUGINOSA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84879294184     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/697972     Document Type: Article

References (27)

1. Aird W. C., Phenotypic heterogeneity of the endothelium-I. Structure, function, and mechanisms. Circulation Research 2007 100 2 158 173 2-s2.0-33846798106 10.1161/01.RES.0000255691.76142.4a
2. Pober J. S., Sessa W. C., Evolving functions of endothelial cells in inflammation. Nature Reviews Immunology 2007 7 10 803 815 2-s2.0-34748914299 10.1038/nri2171
3. Hack C. E., Zeerleder S., Dhainaut J. F., Taylor F., Reinhart K., The endothelium in sepsis: source of and a target for inflammation. Critical Care Medicine 2001 29 7 S21 S27 2-s2.0-0034918411
4. Matsuda N., Hattori Y., Vascular biology in sepsis: pathophysiological and therapeutic significance of vascular dysfunction. Journal of Smooth Muscle Research 2007 43 4 117 137 2-s2.0-35649015324 10.1540/jsmr.43.117
5. Aird W. C., Endothelium in health and disease. Pharmacological Reports 2008 60 1 139 143 2-s2.0-42549157140
6. Levy M. M., Fink M. P., Marshall J. C., Abraham E., Angus D., Cook D., Cohen J., Opal S. M., Vincent J. L., Ramsay G., 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Critical Care Medicine 2003 31 4 1250 1256 2-s2.0-0037389094 10.1097/01.CCM.0000050454.01978.3B
7. Rittirsch D., Flierl M. A., Ward P. A., Harmful molecular mechanisms in sepsis. Nature Reviews Immunology 2008 8 10 776 787 2-s2.0-52949118458 10.1038/nri2402
8. Pittoni G. M., Scatto A., Economics and outcome in the intensive care unit. Current Opinion in Anaesthesiology 2009 22 2 232 236 2-s2.0-68049084782 10.1097/ACO.0b013e328323f9a8
9. Hotchkiss R. S., Karl I. E., The pathophysiology and treatment of sepsis. New England Journal of Medicine 2003 348 2 138 150 2-s2.0-0037426726 10.1056/NEJMra021333
10. Panagiotou A., Gaiao S., Cruz D. N., Extracorporeal therapies in sepsis. Journal of Intensive Care Medicine 2011
11. Peng Z. Y., Wang H. Z., Carter M. J., Acute removal of common sepsis mediators does not explain the effects of extracorporeal blood purification in experimental sepsis. Kidney International 2012 81 363 369
12. Schildberger A., Rossmanith E., Weber V., Falkenhagen D., Monitoring of endothelial cell activation in experimental sepsis with a two-step cell culture model. Innate Immunity 2010 16 5 278 287 2-s2.0-78649644431 10.1177/ 1753425909341885
13. Schildberger A., Buchacher T., Weber V., Falkenhagen D., Adsorptive modulation of inflammatory mediators dampens endothelial cell activation. Blood Purification 2011 32 286 295
14. Sharif O., Bolshakov V. N., Raines S., Newham P., Perkins N. D., Transcriptional profiling of the LPS induced NF- B response in macrophages. BMC Immunology 2007 8, article 1 2-s2.0-33846850216 10.1186/1471-2172-8-1
15. Kellum J. A., Song M., Venkataraman R., Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor- B DNA binding, and improves short-term survival in lethal endotoxemia. Critical Care Medicine 2004 32 3 801 805 2-s2.0-1542719614 10.1097/01.CCM.0000114997. 39857.69
16. Tetta C., Cavaillon J. M., Schulze M., Ronco C., Ghezzi P. M., Camussi G., Serra A. M., Curti F., Lonnemann G., Removal of cytokines and activated complement components in an experimental model of continuous plasma filtration coupled with sorbent adsorption. Nephrology Dialysis Transplantation 1998 13 6 1458 1464 2-s2.0-0031778975 10.1093/ndt/13.6.1458
17. Cantaluppi V., Weber V., Lauritano C., Figliolini F., Beltramo S., Biancone L., De Cal M., Cruz D., Ronco C., Segoloni G. P., Tetta C., Camussi G., Protective effect of resin adsorption on septic plasma-induced tubular injury. Critical Care 2010 14 1, article R4 2-s2.0-77649288355 10.1186/cc8835
18. Qin Z., The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature. Atherosclerosis 2012 221 2 11
19. Altieri D. C., Edgington T. S., The saturable high affinity association of factor X to ADP-stimulated monocytes defines a novel function of the Mac-1 receptor. Journal of Biological Chemistry 1988 263 15 7007 7015 2-s2.0-0023891934
20. Kaplanski G., Marin V., Fabrigoule M., Boulay V., Benoliel A. M., Bongrand P., Kaplanski S., Farnarier C., Thrombin-activated human endothelial cells support monocyte adhesion in vitro following expression of intercellular adhesion molecule-1 (ICAM-1; CD54) and vascular cell adhesion molecule-1 (VCAM-1; CD106). Blood 1998 92 4 1259 1267 2-s2.0-0032529677
21. Krakauer T., A sensitive ELISA for measuring the adhesion of leukocytic cells to human endothelial cells. Journal of Immunological Methods 1994 177 1-2 207 213 2-s2.0-0028593860 10.1016/0022-1759(94)90158-9
22. Sneddon A. A., McLeod E., Wahle K. W. J., Arthur J. R., Cytokine-induced monocyte adhesion to endothelial cells involves platelet-activating factor: suppression by conjugated linoleic acid. Biochimica et Biophysica Acta 2006 1761 7 793 801 2-s2.0-33746287145 10.1016/j.bbalip.2006.05.014
23. Reinhart K., Meisner M., Brunkhorst F. M., Markers for sepsis diagnosis: what is useful? Critical Care Clinics 2006 22 3 503 519 2-s2.0-33746754668 10.1016/j.ccc.2006.03.003
24. Palacio J. R., Markert U. R., Martinez P., Anti-inflammatory properties of N-acetylcysteine on lipopolysaccharide-activated macrophages. Inflammation Research 2011 60 695 704
25. Wehrhahn J., Kraft R., Harteneck C., Hauschildt S., Transient receptor potential melastatin 2 is required for lipopolysaccharide-induced cytokine production in human monocytes. Journal of Immunology 2010 184 5 2386 2393 2-s2.0-77951893358 10.4049/jimmunol.0902474
26. Dehus O., Hartung T., Hermann C., Endotoxin evaluation of eleven lipopolysaccharides by whole blood assay does not always correlate with Limulus amebocyte lysate assay. Journal of Endotoxin Research 2006 12 3 171 180 2-s2.0-33745963648 10.1179/096805106X102156
27. Schwanzer-Pfeiffer D., Roßmanith E., Schildberger A., Falkenhagen D., Characterization of SVEP1, KIAA, and SRPX2 in an in vitro cell culture model of endotoxemia. Cellular Immunology 2010 263 1 65 70 2-s2.0-77952551332 10.1016/j.cellimm.2010.02.017